Fox Chase Postdoctoral Researcher Charline Ogier Receives Prestigious Pancreatic Cancer Action Network Award

PHILADELPHIA (July 22, 2021)—Charline Ogier, PhD, a postdoctoral researcher at Fox Chase Cancer Center, was recently awarded a fellowship from the Pancreatic Cancer Action Network (PanCAN) to continue her work in advancing pancreatic cancer therapies.

PanCAN is a leading nonprofit in the fight against pancreatic cancer. Recipients of its 2021 research grants and grant extensions were recently announced, including 11 newly awarded grants and two previously funded grants.

Ogier, a postdoctoral fellow at the Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase, was selected to receive a 2021 PanCAN Fellowship funded by the Francois Wallace Monahan Fund in loving memory of Michael Insel. The grant will fund her work on a collaborative project with Igor Astsaturov, MD, PhD, and Edna Cukierman, PhD, who are co-directors of the institute.

Ogier will receive $150,000 in funding over two years to continue work on suppressing Netrin-1, a critical secreted ligand that promotes metastases. The molecule is currently in clinical trials.

“If this project is a success, which I hope it is, it’s a very good option for other patients who are not candidates for surgery. We have so many ways to fight pancreatic cancer and most of them are failures because it’s so deadly. Being able to help these patients with metastatic cancer is going to be great,” said Ogier.

She added that in addition to providing possible avenues for pancreatic cancer treatment, this grant means a great deal to her personally as a young scientist whose work is now recognized by other scientists in the field.

“At PanCAN, we recognize that research is critical in the fight to improve outcomes for pancreatic cancer patients, and we will continue to invest significant dollars into this arena to support and build the research community,” said Julie Fleshman, JD, MBA, president and CEO of PanCAN. “Thanks to the support of our generous donors, we are proud to be funding so many innovative research projects this year.”

Since 2003, PanCAN’s grants program has awarded 218 grants to 203 scientists at 75 institutions. Beyond research funding, grant recipients also gain access to PanCAN’s Community for Progress, a cohesive network of researchers focused on improving pancreatic cancer patient outcomes through mentorship and collaboration.

According to PanCAN, career development awardees go on to receive an average of $31.23 in subsequent pancreatic cancer research funding for every dollar PanCAN has invested in them. Awardees across all PanCAN grant types go on to receive an average of $11.50 in subsequent funding for each dollar PanCAN has invested. Additionally, PanCAN grant funding during the evaluation period has resulted in more than 2,700 scientific publications and those publications were cited more than 260,000 times.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427